Brief: Volitionrx Limited Extends Clinical Trial Program In Lung Cancer

VolitionRX

03/04/2019 13:32

April 3 (Reuters) - VolitionRX Ltd  VNRX.A :
    * VOLITIONRX LIMITED EXTENDS CLINICAL TRIAL PROGRAM IN LUNG
CANCER
    * VOLITIONRX LTD - EXPECT TO RELEASE PRELIMINARY DATA
RELATING TO
FIRST 600 PATIENT SAMPLES TO BE REPORTED IN Q1 OF 2020
    * VOLITIONRX - EXPECT TO RELEASE PRELIM DATA FROM LUNG
CANCER
TRIAL RELATING TO FIRST 600 PATIENT SAMPLES TO BE REPORTED IN Q1
2020

Source text for Eikon:  ID:nPn90VhGHa 
Further company coverage:  VNRX.A 

 ((Reuters.Briefs@thomsonreuters.com;))